COMMUNIQUÉS West-GlobeNewswire

VALNEVA : Déclaration d'actions et de droits de vote - OCTOBRE 2018
05/11/2018
VALNEVA Déclaration d'actions et de droits de vote - OCTOBRE 2018 Dénomination sociale : VALNEVA Adresse du siège social : 6 rue Alain Bombard, 44800 Saint-Herblain Marché réglementé Euronext Paris de Nyse Euronext - [...]
Sanofi: Disclosure of trading in own shares
05/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
05/11/2018
Pièce jointe Reporting FR.pdf
Monthly information related to total number of voting rights and shares composing the share capital – October 31, 2018
05/11/2018
LYON, France, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France Listing markets: Euronext Paris from Euronext (Market segment B - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 octobre 2018
05/11/2018
LYON, France, 05 nov. 2018 (GLOBE NEWSWIRE) -- Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France Places de cotation : Euronext Paris de Euronext (Compartiment B - Code ISIN : [...]
Nicox: Number of voting rights as of October 31.2 018
05/11/2018
Nicox SA Société anonyme with a registered capital of € 29,715,320 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On November 5, 2018, MONTHLY PUBLICATION OF THE [...]
Nicox : Nombre de droits de vote au 31 octobre 2018
05/11/2018
Nicox SA Société anonyme au capital de 29 715 320 euros Siège social : DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 Le 5 novembre 2018, PUBLICATION MENSUELLE DU NOMBRE D' [...]
Ossur Hf : Transactions in relation to share buyback program
05/11/2018
Announcement no. 65/2018 5 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Tabula Rasa Healthcare Announces Time Change for Release of Third Quarter 2018 Operating Results and Conference Call
05/11/2018
MOORESTOWN, N.J., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a healthcare technology company advancing the field of medication safety, will now release its third quarter 2018 operating [...]
The Delta Companies Is Recertified by The Joint Commission
05/11/2018
2018 marks the firm’s 10 th consecutive year to receive the prestigious Health Care Staffing Services designation DALLAS, Nov. 05, 2018 (GLOBE NEWSWIRE) -- The Delta Companies (TDC), a leading staffing firm for [...]
RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD
05/11/2018
RECORDATI RECEIVES ORPHAN DRUG DESIGNATION FOR ITS INVESTIGATIONAL TREATMENT FOR MSUD Milan, 5 November 2018 – Recordati today announced that the European Commission (EC) has granted Orphan Drug Designation to Orphan [...]
Innovate Biopharmaceuticals Announces Presentation at the BIO-Europe Conference, Copenhagen 2018 - 24th Annual Partnering Conference
05/11/2018
RALEIGH, N.C., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Innovate) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune and [...]
Golden Leaf Holdings Reports Fiscal Third Quarter 2018 Results
05/11/2018
TORONTO, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (“Golden Leaf” or the “Company”) (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around [...]
Achaogen Announces Review of Strategic Alternatives and Corporate Restructuring
05/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 05, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]
OrthoPediatrics Corp. to Participate in Two Upcoming Conferences
05/11/2018
WARSAW, Ind., Nov. 05, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ:KIDS), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark Throdahl, President & [...]
Mapi Pharma Ltd. Announces Closing of $10 Million Investment by Zhejiang Jingxin Pharmaceutical Co.
05/11/2018
NESS ZIONA, Israel, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Mapi Pharma Ltd., a privately held, fully integrated, clinical stage biopharmaceutical company has completed an equity investment of $10 million by Zhejiang Jingxin [...]
Qu Biologics’ Site Specific Immunomodulators Enhance Adoptive T cell Therapies in Solid Tumours
05/11/2018
VANCOUVER, British Columbia, Nov. 05, 2018 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore [...]
Advantis Corp Forcasts 20% Quarterly Revenue Growth, Increased Margins
05/11/2018
NEWPORT BEACH, CA, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) CEO, Darren Cherry, took some time to update shareholders on the current progress of company operations. [...]
The New Player in the CBD Beverage Space -- CFN Media
05/11/2018
SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]

Pages